Weber M - Search Results

1

Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL. Swerdlow NR, et al. Among authors: weber m. Psychopharmacology (Berl). 2008 Aug;199(3):331-88. doi: 10.1007/s00213-008-1072-4. Epub 2008 Jun 21. Psychopharmacology (Berl). 2008. PMID: 18568339 Free PMC article. Review.

2

Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies.

Qu Y, Swerdlow NR, Weber M, Stouffer D, Parsons LH. Qu Y, et al. Among authors: weber m. Pharmacol Biochem Behav. 2008 Oct;90(4):686-90. doi: 10.1016/j.pbb.2008.05.012. Pharmacol Biochem Behav. 2008. PMID: 18579193 Free PMC article.

3

Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44.

Weber M, Chang WL, Durbin JP, Park PE, Luedtke RR, Mach RH, Swerdlow NR. Weber M, et al. Pharmacol Biochem Behav. 2009 Aug;93(2):141-7. doi: 10.1016/j.pbb.2009.04.022. Epub 2009 May 6. Pharmacol Biochem Behav. 2009. PMID: 19426754 Free PMC article.

4

The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice.

Chang WL, Geyer MA, Buell MR, Weber M, Swerdlow NR. Chang WL, et al. Among authors: weber m. Behav Pharmacol. 2010 Mar;21(2):135-43. doi: 10.1097/FBP.0b013e328337be7e. Behav Pharmacol. 2010. PMID: 20215963 Free PMC article.

5

The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats.

Weber M, Chang WL, Breier MR, Yang A, Millan MJ, Swerdlow NR. Weber M, et al. Eur Neuropsychopharmacol. 2010 Jun;20(6):421-5. doi: 10.1016/j.euroneuro.2010.02.011. Epub 2010 Mar 25. Eur Neuropsychopharmacol. 2010. PMID: 20346635 Free PMC article.

6

Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats.

Chang WL, Swerdlow NR, Breier MR, Thangaraj N, Weber M. Chang WL, et al. Among authors: weber m. Pharmacol Biochem Behav. 2010 Jun;95(4):473-8. doi: 10.1016/j.pbb.2010.04.001. Epub 2010 Apr 10. Pharmacol Biochem Behav. 2010. PMID: 20385162 Free PMC article.

7

Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine.

Weber M, Breier M, Ko D, Thangaraj N, Marzan DE, Swerdlow NR. Weber M, et al. Psychopharmacology (Berl). 2009 May;203(4):723-35. doi: 10.1007/s00213-008-1419-x. Epub 2008 Dec 9. Psychopharmacology (Berl). 2009. PMID: 19066855 Free PMC article.

8

Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation.

Weber M, Chang WL, Breier M, Ko D, Swerdlow NR. Weber M, et al. Behav Pharmacol. 2008 Dec;19(8):786-95. doi: 10.1097/FBP.0b013e32831c3b2b. Behav Pharmacol. 2008. PMID: 19020413 Free PMC article.

9

A novel visuospatial priming task for rats with relevance to Tourette syndrome and modulation of dopamine levels.

Amitai N, Weber M, Swerdlow NR, Sharp RF, Breier MR, Halberstadt AL, Young JW. Amitai N, et al. Among authors: weber m. Neurosci Biobehav Rev. 2013 Jul;37(6):1139-49. doi: 10.1016/j.neubiorev.2012.09.007. Epub 2012 Sep 23. Neurosci Biobehav Rev. 2013. PMID: 23010529 Free PMC article. Review.

10

Opposite effects of tolcapone on amphetamine-disrupted startle gating in low vs. high COMT-expressing rat strains.

Swerdlow NR, Hines SR, Herrera SD, Weber M, Breier MR. Swerdlow NR, et al. Among authors: weber m. Pharmacol Biochem Behav. 2013 May;106:128-31. doi: 10.1016/j.pbb.2013.03.015. Epub 2013 Apr 6. Pharmacol Biochem Behav. 2013. PMID: 23567203 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,207 results

Search Page

Filters